RecruitingMultiple Myeloma

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Eligible age

18+ yrs

Accepts

All genders

Locations

18 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-cel), and to characterize and understand the long-term safety profile of cilta-cel.

Sponsor: Janssen Research & Development, LLC

You may qualify if…

✓ Participants who have received at least one dose of cilta-cel in a Company-sponsored clinical study
✓ Participants who have provided informed consent for this study